xCures is hosting its Community Virtual Event gathering executives from pharmaceutical companies focused on development and commercialization, as well as entrepreneurs and investors involved in oncology solutions. The event will overview xCures' use cases and offerings for various profiles of clients and partners, with live Q&A.
Please RSVP to request live or recorded access to our virtual event, and take the Access Survey - the Visionary team will then be in touch.
Insights & Offerings From:
The platform was created based on the experience of working with 10,000+ advanced cancer patients over the last decade.
xCures manages ultra-efficient decentralized (virtual) trials, expanded access programs, and prospective observational studies.
The platform can be used to prospectively generate real world evidence (RWE) from cancer patients.
Clinical data is obtained by direct patient engagement and enrollment in a longitudinal outcome registry XCELSIOR (NCT03793088) and centrally structured in a source-verified electronic cloud database.
The AI-assisted platform structures clinical data without any additional administrative burden to the patient or the physician
The platform is used to accelerate clinical development of investigational agents and expand the indications for approved agents.
Past programs have used RWE generated by the xCures platform in regulatory filings integrated with clinical trials data.
Used by Oncoceutics, BioMed Valley Discoveries, the POETIC Consortium, Cancer Commons and CTCA.
Currently Seeking: Companies with oncology focused development and commercialization initiatives who cannot get answers to their questions using retrospective databases.